CN Patent

CN102746337B — 一种2，4-嘧啶二胺类化合物及其制备方法

Assigned to Chengdu Easton Biopharmaceuticals Co Ltd · Expires 2014-12-17 · 11y expired

What this patent protects

本发明属于药物化学合成领域，具体涉及到一种2,4-嘧啶二胺类化合物及其制备方法和用途。通过体外实验证明，本发明的化合物能够显著抑制SYK激酶活性。同时，通过对胶原诱导型类风湿关节炎大鼠模型考察，本发明化合物显示了较好的抗炎作用，可用于制备治疗类风湿性关节炎药物。

USPTO Abstract

本发明属于药物化学合成领域，具体涉及到一种2,4-嘧啶二胺类化合物及其制备方法和用途。通过体外实验证明，本发明的化合物能够显著抑制SYK激酶活性。同时，通过对胶原诱导型类风湿关节炎大鼠模型考察，本发明化合物显示了较好的抗炎作用，可用于制备治疗类风湿性关节炎药物。

Drugs covered by this patent

fostamatinib-disodium (FOSTAMATINIB DISODIUM)

Patent Metadata

Patent number: CN102746337B
Jurisdiction: CN
Classification: —
Expires: 2014-12-17
Drug substance claim: No
Drug product claim: No
Assignee: Chengdu Easton Biopharmaceuticals Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.